HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of three cDNAs encoding two isozymes of an isoaspartyl protein carboxyl methyltransferase from human erythroid leukemia cells.

Abstract
Two different sizes (approximately 1.0 and 1.6 kb) of transcripts of an isoaspartyl protein carboxyl methyltransferase (PIMT) were detected in eight cell lines derived from human hemopoietic cells on Northern blot analysis. We found three different sizes of cDNAs (907, 1,553, and 1,600 bp) in human erythroid leukemia cells (HEL) and a unique cDNA sequence corresponding to the 1.0 kb transcript was identified. These three cDNA sequences encoded two isozymes consisting of 226 (isozyme I) and 227 (isozyme II) amino acids. The 1.6 kb transcript was translated into two isozymes (isozyme I and II), while the 1.0 kb transcript was only translated into isozyme I. These results suggest that the two isozymes deduced from the cDNAs of the human erythroid leukemia cells may exist in normal human erythrocytes.
AuthorsR Takeda, M Mizobuchi, K Murao, M Sato, J Takahara
JournalJournal of biochemistry (J Biochem) Vol. 117 Issue 4 Pg. 683-5 (Apr 1995) ISSN: 0021-924X [Print] England
PMID7592526 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA, Neoplasm
  • Isoenzymes
  • RNA, Neoplasm
  • Protein Methyltransferases
  • Protein D-Aspartate-L-Isoaspartate Methyltransferase
Topics
  • Amino Acid Sequence
  • Animals
  • Base Sequence
  • Blotting, Northern
  • Brain (enzymology)
  • DNA, Neoplasm (genetics)
  • Gene Amplification
  • Humans
  • Isoenzymes (genetics)
  • Leukemia, Erythroblastic, Acute (enzymology, genetics)
  • Male
  • Molecular Sequence Data
  • Polymerase Chain Reaction
  • Protein D-Aspartate-L-Isoaspartate Methyltransferase
  • Protein Methyltransferases (genetics)
  • RNA, Neoplasm (genetics)
  • Rats
  • Testis (enzymology)
  • Transcription, Genetic
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: